Lacto-N-fucopentaose II

Lacto-N-fucopentaose II (LNFP II), a sialyl-Lewis hapten of the human Lewis blood group determinant, acts as a monosialo-ganglioside/glycolipid and sialyl derivative, CA 19-9, and is recognized as a molecular tumor marker (TM) for biliopancreatic malignancy [1].

O([C@H]1[C@H](O[C@H]2[C@@H](O)[C@H](O)[C@H](O)[C@H](C)O2)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](O[C@@H]([C@@H]([C@H](C=O)O)O)[C@@H](CO)O)O[C@H](CO)[C@@H]3O)[C@@H]1NC(C)=O)[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O